Published in Cell Immunol on March 01, 1973
Antibody formation in mouse bone marrow. III. Effects of route of priming and antigen dose. Immunology (1974) 1.12
Clonal memory. I. Time-course of proliferation of B-memory cells. J Exp Med (1974) 0.79
STUDIES OF UREA EXCRETION. III: The Influence of Body Size on Urea Output. J Clin Invest (1928) 45.56
STUDIES OF UREA EXCRETION: VI. Comparison of the Blood Urea Clearance with Certain Other Measures of Renal Function. J Clin Invest (1930) 7.46
Studies on antigen-binding cells. I. The origin of reactive cells. Cell Immunol (1970) 2.53
Transplantation of porcine fetal pancreas to diabetic patients. Lancet (1994) 2.52
"Spontaneous" B cell activation due to loss of normal mouse serum suppressor. Eur J Immunol (1972) 2.38
Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells. Science (1990) 2.32
Effects of anti-Ia sera on mitogenic responses. II. Differential expression of the Ia marker on phytohemagglutinin and concanavalin A-reactive T cells. J Exp Med (1976) 2.12
Regional chemotherapy devices: effect of experience and anatomy on complications. J Clin Oncol (1993) 2.09
Phase-coupling of theta-gamma EEG rhythms during short-term memory processing. Int J Psychophysiol (2002) 2.09
Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery (1982) 1.99
Serological and functional evidence for further subdivision of the I regions of the H-2 gene complex. Cold Spring Harb Symp Quant Biol (1977) 1.91
Transcriptomic and proteomic patterns of systemic inflammation in on-pump and off-pump coronary artery bypass grafting. Circulation (2005) 1.83
Polyclonal antibody secretion in human lymphocytes induced by killed staphylococcal bacteria and by lipopolysaccharide. Scand J Immunol (1977) 1.82
Reoperative surgery for periampullary adenocarcinoma. Arch Surg (1991) 1.73
Xylene-free method for histological preparation: a multicentre evaluation. Lab Invest (2001) 1.70
Inhibition of immune responses in vitro by specific antiserums to Ia antigens. Science (1975) 1.65
Effects of anti-Ia sera on mitogenic responses. III. Mapping the genes controlling the expression of Ia determinants on concanavalin A-reactive cells to the I-J subregion of the H-2 gene complex. J Exp Med (1976) 1.60
Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen. Cytokine detection by immunoassay and intracellular immunostaining. J Immunol Methods (1993) 1.60
HLA and rheumatoid arthritis. A study of five families. Tissue Antigens (1981) 1.58
The role of I region gene products in macrophage - T lymphocyte interaction. Immunol Rev (1978) 1.58
HL-A antigens in sarcoidosis. Tissue Antigens (1973) 1.55
Plaque-formation by non-immune and x-irradiated lymphoid cells on monolayers of mouse embryo cells. Nature (1965) 1.55
Spleen cells from animals tolerant to a thymus-dependent antigen can be activated by lipopolysaccharide to synthesize antibodies against the tolerogen. J Exp Med (1976) 1.48
Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection. J Virol (1993) 1.48
Experience with subcutaneous infusion ports in three hundred patients. Surg Gynecol Obstet (1988) 1.47
Role of polyclonal activation in specific immune responses. Relevance for findings of antibody activity in various diseases. Scand J Immunol (1980) 1.46
What is a surgical oncologist? Ann Surg Oncol (1994) 1.40
Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci U S A (1989) 1.36
Effects of anti-Ia serum on mitogenic responses. I. Inhibition of the proliferative response to B cell mitogen, LPS, by specific anti-Ia sera. J Immunol (1975) 1.36
Antigen binding cells in tolerant animals. Nature (1970) 1.35
National patterns of care for pancreatic cancer. Results of a survey by the Commission on Cancer. Ann Surg (1996) 1.35
In vitro assay of cell-mediated immunity: the inhibition of migration of sensitized human lymphocytes by HL-A antigens. Clin Exp Immunol (1970) 1.32
Scandiatransplant: preliminary report of a kidney exchange program. Transplant Proc (1971) 1.32
Studies on antigen-binding cells. II. Relationship to antigen-sensitive cells. Cell Immunol (1970) 1.31
B-cell mitogenic effects on human lymphocytes of rabbit anti-human beta 2-microglobulin. Scand J Immunol (1975) 1.27
Surgical considerations in the management of hepatic neoplasia. Semin Oncol (1983) 1.24
Role of I-region gene products in macrophage induction of an antibody response. II. Restriction at the level of T cell in recognition of I-J-subregion macrophage determinants. J Exp Med (1980) 1.24
The role of adherent cells in B and T lymphocyte activation. Immunol Rev (1978) 1.23
Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time. Transfusion (1998) 1.21
HLA-DR-DQ haplotypes defined by restriction fragment analysis. Correlation to serology. Hum Immunol (1987) 1.20
Complete heart block--another HLA B27 associated disease manifestation. Tissue Antigens (1983) 1.16
CD13 (human aminopeptidase N) mediates human cytomegalovirus infection. J Virol (1993) 1.14
B-cell activation of peripheral blood lymphocytes from patients with chronic lymphatic leukaemia. Clin Exp Immunol (1978) 1.14
Cytotoxicity by nonimmune allogeneic lymphoid cells. Specific suppression by antibody treatment of the lymphoid cells. J Exp Med (1967) 1.12
Definition of hepatic tumor microcirculation by single photon emission computerized tomography (SPECT). J Nucl Med (1984) 1.12
Only one DQ-beta restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes. J Immunol (1986) 1.11
Induction of antibody synthesis in human B lymphocytes by different polyclonal B cell activators: evaluation by direct and indirect PFC assays. Immunol Rev (1979) 1.10
Regional chemotherapy of colorectal cancer metastatic to the liver. Cancer (1984) 1.10
An improved method for preparing anti-B lymphocyte serum. Nat New Biol (1971) 1.09
Expression of Ia antigens on T and B cells and their relationship to immune-response functions. Transplant Rev (1976) 1.09
Antigen-specific T cell activation results in an increase in cytoplasmic free calcium. J Immunol (1985) 1.09
Synovial fluid cytokines in patients with rheumatoid arthritis or other arthritic lesions. Scand J Immunol (1998) 1.08
Malignant clear cell acrospiroma. Cancer (1978) 1.07
The alpha chain, not the beta chain of HLA-DR antigens participates in activation of T cells in autologous mixed lymphocyte reaction. Immunogenetics (1982) 1.07
The expression of Ia antigenic determinants on macrophages required for the in vitro antibody response. J Immunol (1979) 1.07
B cell differentiation factor in synovial fluid of patients with rheumatoid arthritis. Immunol Rev (1984) 1.07
HLA phenotypes and diabetic retinopathy. Diabetologia (1978) 1.06
HLA haplotypes in families with high frequency of multiple sclerosis. Arch Neurol (1976) 1.04
Effects of some immunosuppressive procedures on myasthenia gravis. Ann N Y Acad Sci (1976) 1.04
Optimal conditions for polyclonal antibody secretion and DNA synthesis in human blood and spleen lymphocytes by lipopolysaccharide. Scand J Immunol (1978) 1.04
Antibody production and DNA synthesis of human lymphocyte subpopulations induced by PPD tuberculin. Clin Exp Immunol (1979) 1.03
The use of bacteria for the functional characterization of human lymphocyte subpopulations in various lymphoid organs. Scand J Immunol (1978) 1.03
HLA-A,B,C and DR antigens in psoriasis. Tissue Antigens (1981) 1.00
Neutropenia and insufficiency of the exocrine pancreas. Acta Paediatr Scand (1967) 1.00
Residual C-peptide excretion is associated with a better long-term glycemic control and slower progress of retinopathy in type I (insulin-dependent) diabetes mellitus. J Diabet Complications (1991) 1.00
HLA-DR beta genes vary in number between different DR specificities, whereas the number of DQ beta genes is constant. J Immunol (1985) 0.99
Mitogen-induced differentiation of human CLL lymphocytes to antibody-secreting cells. Scand J Immunol (1979) 0.99
Unilateral, isometric bite force in 8-68-year-old women and men related to occlusal factors. Scand J Dent Res (1990) 0.99
Genomic hybridization with class II transplantation antigen cDNA probes as a complementary technique in tissue typing. Hum Immunol (1984) 0.97
Antigenic markers on mouse lymphoid cells: the presence of MBLA on antibody forming cells and antigen binding cells. Cell Immunol (1972) 0.96
The concept of immunological surveillance against neoplasia. Transplant Rev (1976) 0.96
Cytotoxic effects in vitro by lymphoid cells from specifically tolerant animals. Immunology (1969) 0.96
HLA--determination in families with hereditary ataxia. Tissue Antigens (1978) 0.95
Tuberculous meningitis: immune reactions within the central nervous system. Scand J Immunol (1981) 0.95
Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trials. J Clin Oncol (1991) 0.95
HLA-A, -B, -C and -D antigens in male patients with myasthenia gravis. Tissue Antigens (1978) 0.94
Mercury induces polyclonal B cell activation, autoantibody production and renal immune complex deposits in young (NZB x NZW)F1 hybrids. Eur J Immunol (1996) 0.94
Transcription of the blk gene in human B lymphocytes is controlled by two promoters. J Biol Chem (1995) 0.94
Breast feeding and maternal-donor renal allografts. Possibly the original donor-specific transfusion. Transplantation (1984) 0.94
A totally implanted injection port system for blood sampling and chemotherapy administration. JAMA (1984) 0.94
Genetic basis of multiple sclerosis: HLA antigens, disease progression, and oligoclonal IgG in CSF. Acta Neurol Scand (1979) 0.92
High incidence of spontaneous Ig-producing lymphocytes in peripheral blood and synovial fluid of patients with active seropositive rheumatoid arthritis. Scand J Immunol (1982) 0.92
Xenograft rejection of porcine islet-like cell clusters in normal and natural killer cell-depleted mice. Transplantation (1996) 0.91
Neutralization of human cytomegalovirus by human CD13-specific antibodies. J Infect Dis (1996) 0.91
Characterization of human adenoid cells using surface and functional markers for lymphocyte subpopulations. Clin Exp Immunol (1977) 0.91
Pneumonia in recipients of renal allografts. Arch Surg (1976) 0.90
Studies on the major histocompatibility system in patients with ankylosing spondylitis. Tissue Antigens (1975) 0.90
Markedly elevated serum IgE levels following allogeneic and syngeneic bone marrow transplantation. Blood (1983) 0.90
Identification of five lymphocyte activating determinants in man. Tissue Antigens (1975) 0.90
Myasthenia gravis: studies on HL-A antigens and lymphocyte subpopulations in patients with myasthenia gravis. Clin Exp Immunol (1975) 0.90
Bone marrow-derived macrophage as accessory cells in antigen-induced T cell proliferation. H-2I region requirements for L-glutamic60-L-alanine30-L-tyrosine10 response. J Immunol (1983) 0.89
Considerations of some current concepts in cancer research. J Natl Cancer Inst (1975) 0.89
Adjuvants influence the immunoglobin subclass distribution of immune responses in vivo. Scand J Immunol (1984) 0.89
HLA antigens in selective IgA deficiency: distribution in healthy donors and patients with recurrent respiratory tract infections. Tissue Antigens (1984) 0.89
Utility of lymphoscintigraphy in directing surgical therapy for melanomas of the head, neck, and upper thorax. Surgery (1987) 0.89
Kidney transplantation in the fetal lamb. Technique and histopathology of rejection. Transplantation (1971) 0.88
Antigen-binding cells in immune and tolerant animals. Transplant Rev (1972) 0.87
A DR4-associated DR-DQ haplotype is significantly associated with rheumatoid arthritis. Arthritis Rheum (1988) 0.87
Interleukin 4 and interferon gamma production in restimulated CD4+ and CD8+ cells indicates memory type responsiveness. Scand J Immunol (1991) 0.87